These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 137161)

  • 1. Caffeine potentiation on lethality of L-1210 cells treated with neocarzinostatin.
    Sasada M; Sawada H; Nakamura T; Uchino H
    Gan; 1976 Jun; 67(3):447-9. PubMed ID: 137161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
    Shimoyama M; Kimura K
    Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of caffeine on neocarzinostatin-induced inhibition of cell cycle traverse in HeLa-S3 cells.
    Iseki S; Ebina T; Ishida N
    Cancer Res; 1980 Oct; 40(10):3786-91. PubMed ID: 6449284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A facile method of purification of neocarzinostatin, an antitumor protein.
    Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
    J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of decrease of leukemic cells and leukocytes during neocarzinostatin treatment.
    Masaoka T; Hasegawa Y; Yoshitake J; Ueda T; Takubo T
    Cancer Treat Rep; 1977; 61(1):73-5. PubMed ID: 140763
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydrogen bromide adduct of neocarzinostatin chromophore: one of the stable derivatives of native neocarzinostatin chromophore.
    Edo K; Akiyama-Murai Y; Saito K; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1988 Sep; 41(9):1272-4. PubMed ID: 2972669
    [No Abstract]   [Full Text] [Related]  

  • 8. Zinostatin (neocarzinostatin).
    Issell BF; Prestayko AW; Comis RL; Crooke ST
    Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)].
    Kitajima K
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):767-72. PubMed ID: 4282818
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of acute leukemia with neocarzinostatin (NCS)].
    Masaoka T; Nakamura H; Hasegawa Y; Shibata H; Tatsumi N
    Rinsho Ketsueki; 1974 Dec; 15(12):1309-16. PubMed ID: 4282747
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine-induced recovery from G2 block caused by neocarzinostatin.
    Iseki S; Ebina T; Ishida N
    Gan; 1980 Aug; 71(4):567-71. PubMed ID: 6448762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of neocarzinostatin in patients with acute leukemia.
    Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
    [No Abstract]   [Full Text] [Related]  

  • 14. Neocarzinostatin: a new agent active in the treatment of acute leukemia.
    Kitajima K; Kamimura O; Nagao T; Takahashi I; Hiraki K
    Bibl Haematol; 1975; (40):751-2. PubMed ID: 126059
    [No Abstract]   [Full Text] [Related]  

  • 15. Neocarzinostatin: report of a phase II clinical trial.
    McKelvey EM; Murphy W; Zander A; Bodey GP
    Cancer Treat Rep; 1981; 65(7-8):699-701. PubMed ID: 6454486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of pancreatic carcinoma with neocarzinostatin].
    Kinami Y; Miyazaki H; Koyama F; Noguchi M; Konishi K
    Nihon Gan Chiryo Gakkai Shi; 1975 Dec; 10(4):502-8. PubMed ID: 130432
    [No Abstract]   [Full Text] [Related]  

  • 17. Unscheduled DNA synthesis in human lymphocytes treated with neocarzinostatin.
    Tatsumi K; Sakane T; Sawada H; Shirakawa S; Nakamura T
    Gan; 1975 Aug; 66(4):441-4. PubMed ID: 126891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage and repair in relation to cell killing in neocarzinostatin-treated HeLa cells.
    Hatayama T; Goldberg IH
    Biochim Biophys Acta; 1979 Jun; 563(1):59-71. PubMed ID: 159073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic effects of perioperatively administered neocarzinostatin in renal cell carcinoma.
    Satake I; Tari K; Ohwada F; Saitoh T; Negishi T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):809-16. PubMed ID: 2528598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of malignant glioma with neocarzinostatin. A combined chemoradiotherapy with intra-arterial neocarzinostatin perfusion and irradiation].
    Uemura S; Matsukado Y; Sonoda H; Kuratsu J; Ohtsuka T; Yoshioka S; Yoshida A; Kochi M; Marubayashi T
    Neurol Med Chir (Tokyo); 1986 Apr; 26(4):304-10. PubMed ID: 2429207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.